Telix Pharmaceuticals Ltd
20-F
February 20, 2026
Key Highlights
- Achieved significant revenue growth, primarily from Illuccix, and moved into net...
- Maintained a strong cash position, providing ample liquidity for ongoing operati...
- Advanced a robust R&D pipeline, including late-stage diagnostic candidate Zircai...
Read Analysis
🤖 AI Generated